ロード中...
PCSK9抑制剂对不同基线水平的甘油三酯降低效果不同
OBJECTIVE: To investigate the triglyceride (TG)-lowering effects of PCSK9 inhibitor in patients with in different baseline triglyceride levels. METHODS: Between February, 2019 and March, 2020, a total of 59 patients were treated with PCSK9 inhibitor (Evolocumab) in 5 hospitals, including Nanfang Hos...
保存先:
| 出版年: | Nan Fang Yi Ke Da Xue Xue Bao |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
南方医科大学学报编辑部
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7429163/ https://ncbi.nlm.nih.gov/pubmed/32895189 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.12122/j.issn.1673-4254.2020.08.11 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|